NEW BRUNSWICK, N.J.
Nov. 30, 2012
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has elected
Chairman, Board of Directors of Johnson & Johnson. Mr. Gorsky will assume the Chairman title and additional leadership responsibilities for the global health care company on
Dec. 28, 2012
; Mr. Gorsky was appointed Chief Executive Officer of Johnson & Johnson in April 2012. Current Chairman
will step down as Chairman on
Dec. 28, 2012
, and announced plans to retire in the first quarter of 2013, after a brief transitional period.
"I am truly honored to succeed
as Chairman of Johnson & Johnson," said Mr. Gorsky. "Bill's leadership and contributions to Johnson & Johnson over a 41-year career leave us well-positioned to continue addressing the world's most prevalent diseases and unmet needs in health care. Our financial strength, global reach, and innovations that help people live longer, healthier lives are a proud legacy for Bill and a strong foundation for the future of Johnson & Johnson."
"Throughout his career, leaders from the public and private sector, from business and government, have all turned to Bill for his views on health care and corporate matters – a tribute to his leadership of Johnson & Johnson and his clear thinking on a broad range of complex issues and policies," said Mr. Gorsky. "His advocacy for patients and his strong sense of corporate values will have a lasting influence on our company and our industry."
"Serving as Chairman and CEO of Johnson & Johnson has been a privilege, and I am confident in Alex's ability to lead the people of Johnson & Johnson to even greater achievements," said Weldon. "I would like to thank the people of Johnson & Johnson for all their commitment and dedication to the patients and customers they serve. They bring to life the hope and promise of better treatments, cures, health and well-being for those who use our products. It has been an honor to work with them."